These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38924631)

  • 1. Joint contractures is a recurrent clinical feature of individuals with neurodevelopmental disorder due to FOXP1 likely gene disruptive variants.
    Peduto C; Cappuccio G; Zeuli R; Zanobio M; Torella A; Alkuraya FS; Joss S; Daolio C; Spinelli AM; Zampieri S; ; Nigro V; Brunetti-Pierri N
    Am J Med Genet A; 2024 Jun; ():e63713. PubMed ID: 38924631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole genome sequencing identifies a de novo 2.1 Mb balanced paracentric inversion disrupting FOXP1 and leading to severe intellectual disability.
    Vuillaume ML; Cogné B; Jeanne M; Boland A; Ung DC; Quinquis D; Besnard T; Deleuze JF; Redon R; Bézieau S; Laumonnier F; Toutain A
    Clin Chim Acta; 2018 Oct; 485():218-223. PubMed ID: 29969624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
    Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
    Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Novel
    Benvenuto M; Palumbo P; Di Muro E; Perrotta CS; Mazza T; Mandarà GML; Palumbo O; Carella M
    Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective investigation of FOXP1 syndrome.
    Siper PM; De Rubeis S; Trelles MDP; Durkin A; Di Marino D; Muratet F; Frank Y; Lozano R; Eichler EE; Kelly M; Beighley J; Gerdts J; Wallace AS; Mefford HC; Bernier RA; Kolevzon A; Buxbaum JD
    Mol Autism; 2017; 8():57. PubMed ID: 29090079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment.
    Lozano R; Vino A; Lozano C; Fisher SE; Deriziotis P
    Eur J Hum Genet; 2015 Dec; 23(12):1702-7. PubMed ID: 25853299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring.
    Lozano R; Gbekie C; Siper PM; Srivastava S; Saland JM; Sethuram S; Tang L; Drapeau E; Frank Y; Buxbaum JD; Kolevzon A
    J Neurodev Disord; 2021 Apr; 13(1):18. PubMed ID: 33892622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report of Suspected Gonadal Mosaicism in
    Zsigmond A; Till Á; Bene J; Czakó M; Mikó A; Hadzsiev K
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: Expanding the phenotype of
    Cesaroni CA; Pollazzon M; Mancini C; Rizzi S; Cappelletti C; Pizzi S; Frattini D; Spagnoli C; Caraffi SG; Zuntini R; Trimarchi G; Niceta M; Radio FC; Tartaglia M; Garavelli L; Fusco C
    Front Neurol; 2023; 14():1207176. PubMed ID: 37521304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXP1 mutations cause intellectual disability and a recognizable phenotype.
    Le Fevre AK; Taylor S; Malek NH; Horn D; Carr CW; Abdul-Rahman OA; O'Donnell S; Burgess T; Shaw M; Gecz J; Bain N; Fagan K; Hunter MF
    Am J Med Genet A; 2013 Dec; 161A(12):3166-75. PubMed ID: 24214399
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Meerschaut I; Rochefort D; Revençu N; Pètre J; Corsello C; Rouleau GA; Hamdan FF; Michaud JL; Morton J; Radley J; Ragge N; García-Miñaúr S; Lapunzina P; Bralo MP; Mori MÁ; Moortgat S; Benoit V; Mary S; Bockaert N; Oostra A; Vanakker O; Velinov M; de Ravel TJ; Mekahli D; Sebat J; Vaux KK; DiDonato N; Hanson-Kahn AK; Hudgins L; Dallapiccola B; Novelli A; Tarani L; Andrieux J; Parker MJ; Neas K; Ceulemans B; Schoonjans AS; Prchalova D; Havlovicova M; Hancarova M; Budisteanu M; Dheedene A; Menten B; Dion PA; Lederer D; Callewaert B
    J Med Genet; 2017 Sep; 54(9):613-623. PubMed ID: 28735298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individuals with FOXP1 syndrome present with a complex neurobehavioral profile with high rates of ADHD, anxiety, repetitive behaviors, and sensory symptoms.
    Trelles MP; Levy T; Lerman B; Siper P; Lozano R; Halpern D; Walker H; Zweifach J; Frank Y; Foss-Feig J; Kolevzon A; Buxbaum J
    Mol Autism; 2021 Sep; 12(1):61. PubMed ID: 34588003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: FOXP1 syndrome caused by a
    Chen M; Sun Y; Qian Y; Chen N; Li H; Wang L; Dong M
    Front Genet; 2022; 13():926070. PubMed ID: 35991577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalent missense variant in the FOXP2 and FOXP1 transcription factors causes distinct neurodevelopmental disorders.
    Sollis E; Deriziotis P; Saitsu H; Miyake N; Matsumoto N; Hoffer MJV; Ruivenkamp CAL; Alders M; Okamoto N; Bijlsma EK; Plomp AS; Fisher SE
    Hum Mutat; 2017 Nov; 38(11):1542-1554. PubMed ID: 28741757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a recurrent missense mutation in the forkhead DNA-binding domain of FOXP1.
    Johnson TB; Mechels K; Anderson RH; Cain JT; Sturdevant DA; Braddock S; Pinz H; Wilson MA; Landsverk M; Roux KJ; Weimer JM
    Sci Rep; 2018 Nov; 8(1):16161. PubMed ID: 30385778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) With Language Impairment Accompanied by Developmental Disability Caused by Forkhead Box Protein 1 (FOXP1) Exon Deletion: A Case Report.
    Alenezi S; Alyahya A; Aldhalaan H
    Cureus; 2021 Dec; 13(12):e20595. PubMed ID: 35103171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction and oxidative stress contribute to cognitive and motor impairment in FOXP1 syndrome.
    Wang J; Fröhlich H; Torres FB; Silva RL; Poschet G; Agarwal A; Rappold GA
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35165191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical phenotype of FOXP1 syndrome: parent-reported medical signs and symptoms in 40 individuals.
    Koene S; Ropers FG; Wieland J; Rybak T; Wildschut F; Berghuis D; Morgan A; Trelles MP; Scheepe JR; Bökenkamp R; Peeters-Scholte CMPCD; Braden R; Santen GWE
    J Med Genet; 2024 Mar; 61(4):399-404. PubMed ID: 38123995
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.